戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  reduced starting dose sorafenib (< 800 mg/d per os).
2 rge of the patient with amoxicillin (2 g tid per os).
3  which mice were exposed to aerosolized LPS, per os administration of 3T mannodendrimer was found to
4 uced through the administration of metformin per os and an intraperitoneal injection of lactic acid.
5 ctive, and liberates more than 120 equiv NH3 per Os center in a single batch experiment using Cp*2Co
6  procedure impacted infection outcomes after per os challenge with exogenous bacteria (Enterobacter s
7   Rats were treated with FK506 (1-1.5 mg/kg, per OS daily) for three days beginning 24 hours before e
8 pared famciclovir (Famvir, 500 mg 3x/day po [per os] for 5 days) and topical fluocinonide (0.05% Lide
9 t in vivo, having ED(50) = 0.6 +/- 0.3 mg/kg per os in mice for inhibition of brain N(tau)-methylhist
10 ebral cortex synaptosomes) and in vivo (ED50 per os in mice on brain tele-methylhistamine levels).
11          The dose of gabapentin was 1,800 mg per os, in a single administration.
12  the bite site of the triatomine vector, but per os infection is also a well-documented mode of trans
13                                              Per os infectivity factors PIF1 (Ac119) and PIF2 (Ac022)
14 od that was not significantly different from per os inoculation of the same dose of the HY TME agent.
15                          We isolated the nil per os (npo) mutation, which arrests morphogenesis and c
16 kg body weight in corn oil or corn oil alone per os on days after inoculation (DAI) -1, +1, and +3 wi
17 gens 0.625 mg per os per day, ramipril 10 mg per os per day, and combination estrogens and ramipril.
18 nt with conjugated equine estrogens 0.625 mg per os per day, ramipril 10 mg per os per day, and combi
19 a was uniquely more active when administered per os (po) than subcutan (sc).
20 owth inhibition (TGI) = 75% at 25 mg/kg.day, per os (po)).
21 e archaic practice of patients remaining nil per os postoperatively until return of bowel sounds.
22     Shikonin dose-dependently (0.5-50 mg/kg, per os) prevented DM/hypoxia-induced lesions.
23                     At 1.0 mg kg(-1) day(-1) per os, Pz-1 abrogated the formation of tumors induced b
24 in vivo FRZ treatment (40-110 mg/kg per day, per os) resulted in a dramatic loss of mIPSCs in CA1 neu
25  that intestinal LEPR-B could be a potential per os target for prevention against obesity.
26 m analgesic activities (ED50 < or = 4 mg/kg, per os) that are reversible with an adenosine receptor a
27     The virus was experimentally transmitted per os to several mosquito species.
28 standard starting dosage sorafenib (800 mg/d per os) versus that of patients who were prescribed redu
29 experiment 2, two piglets each were infected per os with A. butzleri ATCC 49616, A. cryaerophilus 1A
30 experiment 1, two piglets each were infected per os with either Arcobacter butzleri ATCC 49616, Arcob
31 y, groups of 10 C57BL/6 mice were inoculated per os with H. hepaticus, Helicobacter muridarum, or H.

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。